Litcius/Paper detail

Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors

Maria Giulia Nizi, Jenny Desantis, Yoshio Nakatani, Serena Massari, Maria Angela Mazzarella, Gauri Shetye, Stefano Sabatini, Maria Letizia Barreca, Giuseppe Manfroni, Tommaso Felicetti, Rowena Rushton-Green, Kiel Hards, Gniewomir Latacz, Grzegorz Satała, Andrzej J. Bojarski, Violetta Cecchetti, Michal H. Kolář, Jadwiga Handzlik, Gregory M. Cook, Scott G. Franzblau, Oriana Tabarrini

2020European Journal of Medicinal Chemistry31 citationsDOIOpen Access PDF

Topics & Concepts

ChemistryLead compoundBedaquilineMycobacterium tuberculosisCombinatorial chemistryEnzymeOxidoreductaseBiochemistryStereochemistryPharmacologyTuberculosisIn vitroMedicinePathologyPhenothiazines and Benzothiazines Synthesis and ActivitiesChemical Reaction MechanismsCancer therapeutics and mechanisms
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors | Litcius